NEW HAVEN, Conn., June 9, 2017 /PRNewswire/ -- Kleo Pharmaceuticals Inc., a biotechnology company pioneering a new class of immunotherapies utilizing small molecules to activate an individual\'s own immune system to fight against cancers and infectious diseases, announced today the...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]ecutive-officer-300471493.html